Last update 01 Nov 2024

CD300LD

Last update 01 Nov 2024

Basic Info

Synonyms

CD300 antigen-like family member D, CD300 molecule like family member d, CD300D

+ [5]

Introduction-

Drugs associated with CD300LD

WO2023088464

Patent Mining

Target

CD300LD

Mechanism

CD300LD inhibitors

Active Org.

Fudan University [+1]

Originator Org.

Fudan University [+1]

Active Indication

Neoplasms

Inactive Indication-

Drug Highest PhaseDiscovery

First Approval Ctry. / Loc.-

First Approval Date20 Jan 1800

100 Clinical Results associated with CD300LD

100 Translational Medicine associated with CD300LD

0 Patents (Medical) associated with CD300LD

Literatures (Medical) associated with CD300LD

01 Oct 2024·Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

[Phenotype and function of neutrophils in normal human peripheral blood].

Article

Author: Zuo, Jiajia ; Xu, Xiaoyue ; Zhang, Chunmei ; Zhang, Yun ; Zhuang, Ran ; Zhang, Yusi ; Ma, Ying ; Zhang, Yuan ; Wang, Shijia

Objective To investigate the phenotypic and functional characteristics of normal human peripheral blood neutrophils. Methods Normal human peripheral blood neutrophils were isolated through density gradient centrifugation followed by red blood cell lysis, and their surface markers and distribution characteristics in different neutrophil subsets were detected using multi-color immunofluorescence staining and flow cytometry. The phagocytic activity of neutrophils was evaluated with pHrodo^TM Green E.coli BioParticles^TM. The morphological characteristics of neutrophils undergoing the formation of neutrophil extracellular traps (NET) in vitro were examined via Wright-Giemsa staining and immunofluorescence staining, and were observed using standard light microscopy and confocal microscopy, respectively. Results CD66b, CD11b and CD16 were all highly expressed on normal human peripheral blood neutrophils and the percentage of CD16 positive neutrophils was higher compared to CD11b positive neutrophils. Neutrophils could be classified into three subsets based on the density of CD16 expression: namely, CD16^hi neutrophil, CD16^int neutrophil and CD16^lo neutrophil. The proportion of the CD16^hi neutrophil was the highest among the three subsets. The inhibitory molecule programmed cell death ligand 1 (PD-L1) was expressed on all neutrophil subsets without significant differences; however, the expression level of another inhibitory molecule, CD300LD, was markedly higher in the CD16^hi neutrophil compared to CD16^int or CD16^lo neutrophil. Each neutrophil subset demonstrated high levels of adhesion molecule CD62L without notable differences. Notably, the mean fluorescence intensity (MFI) value for pHrodo^TM Green E.coli BioParticles^TM in the CD16^int neutrophil was the highest among three subsets; and that in CD16^hi neutrophil was higher compared to CD16^lo neutrophil. Results of Wright-Giemsa staining showed that normal peripheral blood neutrophils typically possessed lobulated nuclei; upon stimulation with phorbol 12-myristate 13-acetate (PMA), the nuclei of these neutrophils formed a network structure while losing their lobulated nuclear morphology. Laser confocal microscopy results showed an increased release of neutrophil elastase (NE) with network formation in neutrophils after PMA stimulation. Conclusions Normal human peripheral blood neutrophils are heterogenous population with different expression of surface marker molecules, which might exert different immune functions. NET formation can be induced by PMA stimulation, and the differences of NET formation in different neutrophil subsets need to be further studied.

01 Sep 2024·Science Bulletin

CD300ld: A new target for tumor immunotherapy and new hope for cancer patients

Article

Author: Guo, Guanqun ; Yang, Gen ; Chen, Huiqin

01 Jul 2024·MedComm

Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy

Article

Author: Zhu, Hai-Dong ; Zhang, Lin-Zhu ; He, Xu

AbstractIn a recent Nature elegant study, Wang et al. identified CD300ld, a novel functionally highly conserved tumor immunosuppressive receptor, highly expressed specifically on polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSCs), as well as a key receptor in the regulation of recruitment and immunosuppressive function of PMN‐MDSCs. Targeting CD300ld could remodel the tumor immune microenvironment, resulting in a broad‐spectrum anti‐tumor effect.

Analysis

Perform a panoramic analysis of this field.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

CD300LD

Basic Info

Related

Analysis